Patents by Inventor Zhouning Zhang

Zhouning Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT ASSAYS AND USES THEREOF
    Publication number: 20160153985
    Abstract: The present invention provides methods for assessing complement activation and methods for assessing the ability of an agent or condition of interest to modulate complement activation. The present invention provides methods for assessing whether a subject has or is at increased risk of developing a complement-mediated disorder, e.g., age-related macular degeneration (AMD). Also provided are kits containing materials useful for performing the methods.
    Type: Application
    Filed: February 9, 2016
    Publication date: June 2, 2016
    Inventors: Zhouning Zhang, Cedric Francois, Pascal Deschatelets, Paul Olson
  • Complement assays and uses thereof
    Patent number: 9291622
    Abstract: The present invention provides methods for assessing complement activation and methods for assessing the ability of an agent or condition of interest to modulate complement activation. The present invention provides methods for assessing whether a subject has or is at increased risk of developing a complement-mediated disorder, e.g., age-related macular degeneration (AMD). Also provided are kits containing materials useful for performing the methods.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: March 22, 2016
    Assignee: Apellis Pharmaceuticals, Inc.
    Inventors: Zhouning Zhang, Cedric Francois, Pascal Deschatelets, Paul Olson
  • COMPLEMENT ASSAYS AND USES THEREOF
    Publication number: 20120135430
    Abstract: The present invention provides methods for assessing complement activation and methods for assessing the ability of an agent or condition of interest to modulate complement activation. The present invention provides methods for assessing whether a subject has or is at increased risk of developing a complement-mediated disorder, e.g., age-related macular degeneration (AMD). Also provided are kits containing materials useful for performing the methods.
    Type: Application
    Filed: May 21, 2010
    Publication date: May 31, 2012
    Applicant: POTENTIA PHARMACEUTICALS, INC.
    Inventors: Zhouning Zhang, Cedric Francois, Pascal Deschatelets, Paul Olson